‌

Aerska

RNA medicines developer to treat, delay, and prevent diseases of the brain.

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Pharmaceutical industry

Health technology

Location

CEO

Founder

David Hardwicke

Stuart Milstein

Number of Employees (Ranges)

11 – 50

Email Address

mail@aerska.com

Investors

BlueYard Capital

PsyMed Ventures

...

Founded Date

2025

Total Funding Amount (USD)

21,000,000

Latest Funding Round Date

October 1, 2025

Latest Funding Type

Country

Republic of Ireland

Headquarters

Other attributes

Latest Funding Round Amount (USD)

21,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Aerska

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool